Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial
- Journal:
- The Lancet Diabetes & Endocrinology
- Published:
- Affiliations:
- 9
- Authors:
- 14
| Institutions | Authors | Share |
|---|---|---|
| University of Copenhagen (UCPH), Denmark | 0.64 | |
| Gentofte University Hospital, Denmark | 0.31 | |
| Steno Diabetes Center Copenhagen (SDCC), Denmark | 0.04 | |
| Bispebjerg University Hospital (BBH), Denmark | 0.01 |